As Vice President Kamala Harris and former President Donald Trump enter the home stretch of their campaigns, both candidates have been financially supported by an increasingly anxious pharma sector.
Big Pharma is big into lobbying, and drugmakers upped their efforts in 2024, with more spending compared to the previous year, Politico reported. And there are several key policy issues at stake, including Medicare’s price negotiation power.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,